Characteristics of Nipah virus and Hendra virus replication in different cell lines and their suitability for antiviral screening

Virus Research

Volumn 142, Issue 1-2, 2009, Pages 92-99

  Aljofan, Mohamad ^a,b   Saubern, Simon ^a   Meyer, Adam G ^a   Marsh, Glenn ^a   Meers, Joanne ^b   Mungall, Bruce A ^a  

^a CSIRO   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antiviral; BSL4; Hendra virus; HTS assays; Nipah virus; Ribavirin

Indexed keywords

ANTIVIRUS AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; RIBAVIRIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CELL STRAIN BHK; CELL STRAIN HEPG2; CELL TYPE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; HELA CELL; HENDRA VIRUS; HENIPAVIRUS INFECTION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MOUSE; NIPAH VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA REPLICATION; VERO CELL; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CATTLE; CELL LINE; CERCOPITHECUS AETHIOPS; DRUG EVALUATION, PRECLINICAL; GUINEA PIGS; HENDRA VIRUS; HUMANS; MICE; NIPAH VIRUS; VERO CELLS; VIRUS REPLICATION;

HENDRA VIRUS; HENIPAVIRUS; NIPAH VIRUS;

EID: 67349241274     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.01.014     Document Type: Article

References (51)

1. Aljofan M., Porotto M., Moscona A., and Mungall B.A. Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus. J. Virol. Methods 149 (2008) 12-19
2. Brown J., Reading S.J., Jones S., Fitchett C.J., Howl J., Martin A., Longland C.L., Michelangeli F., Dubrova Y.E., and Brown C.A. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab. Invest. 80 (2000) 37-45
3. Butler D. Fatal fruit bat virus sparks epidemics in southern Asia. Nature 429 (2004) 7
4. Chadha M.S., Comer J.A., Lowe L., Rota P.A., Rollin P.E., Bellini W.J., Ksiazek T.G., and Mishra A. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg. Infect. Dis. 12 (2006) 235-240
5. Chen M.H., and Icenogle J.P. Rubella virus capsid protein modulates viral genome replication and virus infectivity. J. Virol. 78 (2004) 4314-4322
6. Chong H.T., Kamarulzaman A., Tan C.T., Goh K.J., Thayaparan T., Kunjapan S.R., Chew N.K., Chua K.B., and Lam S.K. Treatment of acute Nipah encephalitis with ribavirin. Ann. Neurol. 49 (2001) 810-813
7. Chua K.B. Nipah virus outbreak in Malaysia. J. Clin. Virol. 26 (2003) 265-275
8. Chua K.B., Bellini W.J., Rota P.A., Harcourt B.H., Tamin A., Lam S.K., Ksiazek T.G., Rollin P.E., Zaki S.R., Shieh W., Goldsmith C.S., Gubler D.J., Roehrig J.T., Eaton B., Gould A.R., Olson J., Field H., Daniels P., Ling A.E., Peters C.J., Anderson L.J., and Mahy B.W. Nipah virus: a recently emergent deadly paramyxovirus. Science 288 (2000) 1432-1435
9. Chua K.B., Goh K.J., Wong K.T., Kamarulzaman A., Tan P.S., Ksiazek T.G., Zaki S.R., Paul G., Lam S.K., and Tan C.T. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet 354 (1999) 1257-1259
10. Crameri G., Wang L.F., Morrissy C., White J., and Eaton B.T. A rapid immune plaque assay for the detection of Hendra and Nipah viruses and anti-virus antibodies. J. Virol. Methods 99 (2002) 41-51
11. De Franceschi L., Fattovich G., Turrini F., Ayi K., Brugnara C., Manzato F., Noventa F., Stanzial A.M., Solero P., and Corrocher R. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 31 (2000) 997-1004
12. Desmyter J., Melnick J.L., and Rawls W.E. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J. Virol. 2 (1968) 955-961
13. Enserink M. Emerging infectious diseases. Nipah virus (or a cousin) strikes again. Science 303 (2004) 1121
14. Field H., Young P., Yob J.M., Mills J., Hall L., and Mackenzie J. The natural history of Hendra and Nipah viruses. Microb. Infect. 3 (2001) 307-314
15. Goh K.J., Tan C.T., Chew N.K., Tan P.S., Kamarulzaman A., Sarji S.A., Wong K.T., Abdullah B.J., Chua K.B., and Lam S.K. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N. Engl. J. Med. 342 (2000) 1229-1235
16. Gurley E.S., Montgomery J.M., Hossain M.J., Bell M., Azad A.K., Islam M.R., Molla M.A., Carroll D.S., Ksiazek T.G., Rota P.A., Lowe L., Comer J.A., Rollin P., Czub M., Grolla A., Feldmann H., Luby S.P., Woodward J.L., and Breiman R.F. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg. Infect. Dis. 13 (2007) 1031-1037
17. Halpin K., and Mungall B.A. Recent progress in henipavirus research. Comp. Immunol. Microbiol. Infect. Dis. 30 (2007) 287-307
18. Halpin K., Young P.L., Field H.E., and Mackenzie J.S. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J. Gen. Virol. 81 (2000) 1927-1932
19. Hatton T., Zhou S., and Standring D.N. RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication. J. Virol. 66 (1992) 5232-5241
20. Helin E., Matikainen S., Julkunen I., Heino J., Hyypia T., and Vainionpaa R. Measles virus enhances the expression of cellular immediate-early genes and DNA-binding of transcription factor AP-1 in lung epithelial A549 cells. Arch. Virol. 147 (2002) 1721-1732
21. Homaira N., Rahman M., Hossain M.J., Khatun S., Nahar N., Podder G., Gurley E.S., Ksiazek T.G., and Luby S.P. Evidence of person-to-person transmission of Nipah virus through casual contact. Int. J. Infect. Dis. 12 (2008) e99-e199
22. Hsu V.P., Hossain M.J., Parashar U.D., Ali M.M., Ksiazek T.G., Kuzmin I., Niezgoda M., Rupprecht C., Bresee J., and Breiman R.F. Nipah virus encephalitis reemergence, Bangladesh. Emerg. Infect. Dis. 10 (2004) 2082-2087
23. Hyatt A.D., and Selleck P.W. Ultrastructure of equine morbillivirus. Virus Res. 43 (1996) 1-15
24. Icddr B. Outbreaks of encephalitis due to Nipah/Hendra-like viruses, Western Bangladesh. Health Sci. Bull. 1 5 (2003) 1-6
25. Icddr B. Nipah encephalitis outbreak over wide area of western Bangladesh, 2004. Health Sci. Bull. 2 1 (2004) 7-11
26. Icddr B. Person-to-person transmission of Nipah virus during outbreak in Faridpur District, 2004. Health Sci. Bull. 2 2 (2004) 5-9
27. Icddr B. Nipah virus outbreak from date palm juice. Health Sci. Bull. 3 4 (2005) 1-5
28. Juozapaitis M., Serva A., Zvirbliene A., Slibinskas R., Staniulis J., Sasnauskas K., Shiell B.J., Wang L.F., and Michalski W.P. Generation of henipavirus nucleocapsid proteins in yeast Saccharomyces cerevisiae. Virus Res. 124 (2007) 95-102
29. Lo M.K., and Rota P.A. The emergence of Nipah virus, a highly pathogenic paramyxovirus. J. Clin. Virol. 43 (2008) 396-400
30. Luby S.P., Rahman M., Hossain M.J., Blum L.S., Husain M.M., Gurley E., Khan R., Ahmed B.N., Rahman S., Nahar N., Kenah E., Comer J.A., and Ksiazek T.G. Foodborne transmission of Nipah virus, Bangladesh. Emerg. Infect. Dis. 12 (2006) 1888-1894
31. Ludlow L.E., Lo M.K., Rodriguez J.J., Rota P.A., and Horvath C.M. Henipavirus V protein association with Polo-like kinase reveals functional overlap with STAT1 binding and interferon evasion. J. Virol. 82 (2008) 6259-6271
32. Mohd Nor M.N., Gan C.H., and Ong B.L. Nipah virus infection of pigs in peninsular Malaysia. Rev. Sci. Technol. 19 (2000) 160-165
33. Mungall B.A., Middleton D., Crameri G., Bingham J., Halpin K., Russell G., Green D., McEachern J., Pritchard L.I., Eaton B.T., Wang L.F., Bossart K.N., and Broder C.C. Feline model of acute Nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. J. Virol. 80 (2006) 12293-12302
34. Mungall B.A., Schopman N.C.T., Lambeth L.S., and Doran T.J. Inhibition of Henipavirus infection by RNA interference. Antivir. Res. 80 (2008) 324-331
35. Murray K., Selleck P., Hooper P., Hyatt A., Gould A., Gleeson L., Westbury H., Hiley L., Selvey L., and Rodwell B. A morbillivirus that caused fatal disease in horses and humans. Science 268 (1995) 94-97
36. Patton J.T., Jones M.T., Kalbach A.N., He Y.W., and Xiaobo J. Rotavirus RNA polymerase requires the core shell protein to synthesize the double-stranded RNA genome. J. Virol. 71 (1997) 9618-9626
37. Porotto M., Carta P., Deng Y., Kellogg G.E., Whitt M., Lu M., Mungall B.A., and Moscona A. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors. J. Virol. 81 (2007) 10567-10574
38. Portela A., and Digard P. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 83 (2002) 723-734
39. Reed L.J., and Muench H. Simple method for estimating fifty percent end points. Am. J. Hyg. 27 (1938) 493-497
40. Reynes J.M., Counor D., Ong S., Faure C., Seng V., Molia S., Walston J., Georges-Courbot M.C., Deubel V., and Sarthou J.L. Nipah virus in Lyle's flying foxes, Cambodia. Emerg. Infect. Dis. 11 (2005) 1042-1047
41. Rhim J.S., and Schell K. Cytopathic and plaque assay of rubella virus in a line of African green monkey kidney cells (Vero). Proc. Soc. Exp. Biol. Med. 125 (1967) 602-606
42. Rodriguez J.J., Cruz C.D., and Horvath C.M. Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J. Virol. 78 (2004) 5358-5367
43. Rodriguez J.J., Parisien J.P., and Horvath C.M. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 76 (2002) 11476-11483
44. Sato M., Tanaka H., Yamada T., and Yamamoto N. Persistent infection of BHK21/WI-2 cells with rubella virus and characterization of rubella variants. Arch. Virol. 54 (1977) 333-343
45. Shaw M.L., Cardenas W.B., Zamarin D., Palese P., and Basler C.F. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J. Virol. 79 (2005) 6078-6088
46. Shaw M.L., Garcia-Sastre A., Palese P., and Basler C.F. Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J. Virol. 78 (2004) 5633-5641
47. Shiell B.J., Gardner D.R., Crameri G., Eaton B.T., and Michalski W.P. Sites of phosphorylation of P and V proteins from Hendra and Nipah viruses: newly emerged members of Paramyxoviridae. Virus Res. 92 (2003) 55-65
48. Sleeman K., Bankamp B., Hummel K.B., Lo M.K., Bellini W.J., and Rota P.A. The C, V and W proteins of Nipah virus inhibit minigenome replication. J. Gen. Virol. 89 (2008) 1300-1308
49. Tacken M.G., Rottier P.J., Gielkens A.L., and Peeters B.P. Interactions in vivo between the proteins of infectious bursal disease virus: capsid protein VP3 interacts with the RNA-dependent RNA polymerase, VP1. J. Gen. Virol. 81 (2000) 209-218
50. Takahashi K., Sawasaki Y., Hata J., Mukai K., and Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev. Biol. 26 (1990) 265-274
51. Wright P.J., Crameri G., and Eaton B.T. RNA synthesis during infection by Hendra virus: an examination by quantitative real-time PCR of RNA accumulation, the effect of ribavirin and the attenuation of transcription. Arch. Virol. 150 (2005) 521-532